fa cil ity and fre quency of their meas urement, this "un pleas ant state" could be spe ciously la belled as anxi ety or dys pho ria.
Per fec tion ists, ob ses sional per son alities, and many yearn ing psy cho ther apy cli ents with di verse pre sent ing prob lems of ten ex pe ri ence fluc tu at ing lev els of an un pleas ant state of as cen dent anxi ety. The lack of a word for this is a gap in the psy cho logi cal lexi con, lead ing to circum lo cu tion. Hor ney's and Rogers's terms may be too pro prie tary to their theo ries and too trait-like. Anxi ety is over gen eral, and con notes ti mid ity; as a dis cus sion about the item con tent of a com monly used psy cho met ric scale high lights, it is usu ally used to em phasize physio logi cal overa rousal, rather than as a per sis tent long ing for selfelevation (22). The noun yumpity, (adjec tive, yumpi tous or yump tious), is offered as a po ten tial so lu tion. Hav ing a word for as cen dent anxi ety-the discom fort ing sub jec tive state of per fection ism-could as sist in the de vel op ment of par si mo ni ous cog ni tive mod els of OCD. It is com fort ing, too, for pa tients, if there is a name for their distress (23). 
Ref er ences

Evaluation of Droperidol in the Acutely Agitated Child or Adolescent
Dear Edi tor:
Dro peri dol is a bu ty ro phe none neu rolep tic that is used pri mar ily as an ad junct to an es the sia. It acts within 3 to 10 min utes af ter an in tra mus cu lar (IM) injec tion, com pared with 20 to 40 min utes with ha loperi dol (1, 2) . It has a short half-life of about 2.2 hours, whereas IM ha loperi dol has a half-life of 10 to 19 hours (2) . Dro peri dol also ap pears to cause marked se da tion, with a lower inci dence of ex tra py ra mi dal and hy potensive side ef fects than does ha loperi dol (3) . Lim ited data, how ever, are avail able on dro peri dol's use in acute agi ta tion in ado les cents. One study that in volved 26 chil dren who were ad min is tered droperi dol for ag gres sive be hav iour showed good re sults with lim ited side ef fects (1) . We re port the pre limi nary find ings of 1 child and 5 ado les cents who were ad min is tered dro peri dol for con trol of ex treme agi ta tion.
We im ple mented a pro to col to evalu ate the use of dro peri dol as a chemi cal restraint in chil dren and ado les cents in the CAPE (Child and Ado les cent Psy chi atric Emer gency) Unit at Brit ish Co lumbia's Chil dren's Hos pi tal. Dro peri dol could be used only for pa tients over age 6 years, with out re nal or he patic dis ease and not in toxi cated, and at ≥ level 3 on the agi ta tion unit scale 1) sleep ing but eas ily aroused, 2) rest less and agi tated, 3) physi cal or ver bal hy per ac tiv ity with threats of vio lence, 4) com bat ive be haviour need ing physi cal re straint (4). Droperi dol IM was ini tially dosed ac cord ing to body weight (< 35 kg, 1.3 mg; 35-55 kg, 1.9 mg; 55-70 kg, 2.5 mg; > 70 kg, 3.1 mg) and ti trated to ef fect. The dose could be re peated within 15 to 30 minutes if in ef fec tive, to a maxi mum of 4 doses daily. Side ef fects were ranked from 0 (no symp toms) to 4 (se vere symp toms) for each dose ad min is tered.
Dur ing a 20-week pe riod, dro peri dol was ad min is tered 20 times to 4 fe males and 2 males in the CAPE Unit. Pa tients had var ied di ag no ses: de pres sion (n = 1); schizo phre nia (n = 1); ob ses sive-compul sive dis or der (OCD) (n = 1); a yetto-be-diagnosed ge netic dis or der ( n = 1); attention-deficit hy per ac tiv ity dis or der (n = 1); and un speci fied psy cho sis (n = 1). They were tak ing con comi tant medica tions such as fluvox am ine, fluoxet ine, and tra zo done. Pa tients' mean (SD) age was 12.8 (3.4) years, mean (SD) weight was 55.9 (6.3) kg, and mean (SD) droperi dol dose was 3.6 (2.1) mg. On set of ef fect was within 10 to 15 min utes and showed a pro found calm ing ef fect on all pa tients. In fact, 4 pa tients were sleep ing 1 hour af ter ad mini stra tion (level 1). We evalu ated the re main ing 2 pa tients at level 2 af ter 1 hour.
One of the pa tients, who re ceived 11 doses, was an obese 80-kg boy aged 8 years. With dos age ti tra tion over a 2-day pe riod, an ap pro pri ate 7-mg dose IM was reached. He did ex hibit some ex trapy ra mi dal symp toms 2 hours af ter the first 7-mg dose and re sponded to 2 mg of oral benz tro pine.
One fe male pa tient ex hib ited a hy potensive epi sode 4.5 hours af ter a 1.9-mg dro peri dol dose, but 3 hours prior to droperi dol, she had also been given 2 mg of lo raze pam and 4 mg of ha loperi dol. Respi ra tory de pres sion was not seen in any pa tient. Drowsi ness (46 points), restless ness (14 points), and nerv ous ness (11 points) were the most com mon side ef fects re corded. All other side-effects scored < 5 points.
Our pre limi nary data show dro peri dol to be a safe and ef fec tive choice for acute agi ta tion in a small and het ero ge ne ous sam ple of chil dren and ado les cents. Further in ves ti ga tions, in clud ing ran domized con trolled tri als, are war ranted in this sub popu la tion.
